Cargando…
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
INTRODUCTION: Meningioma is the most common primary brain tumor. Most meningiomas are benign; however, a subset of these tumors can be aggressive, presenting with early or multiple tumor recurrences that are refractory to neurosurgical resection and radiotherapy. There is no standard systemic therap...
Autores principales: | Karimi, Shirin, Mansouri, Sheila, Nassiri, Farshad, Bunda, Severa, Singh, Olivia, Brastianos, Priscilla K., Dunn, Ian F., Zadeh, Gelareh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897616/ https://www.ncbi.nlm.nih.gov/pubmed/33611710 http://dx.doi.org/10.1007/s11060-020-03584-8 |
Ejemplares similares
-
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
por: Karimi, Shirin, et al.
Publicado: (2020) -
Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors
por: Bunda, Severa, et al.
Publicado: (2021) -
TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy
por: Wei, Qingxia, et al.
Publicado: (2021) -
SHH PATHWAY ACTIVATION DRIVES MALIGNANT TRANSFORMATION IN A SUBSET OF MPNSTS AND IS A POTENTIAL THERAPEUTIC TARGET
por: Suppiah, Suganth, et al.
Publicado: (2023) -
Introduction: Ongoing clinical challenges in the management of meningiomas and future directions
por: Wang, Justin Z, et al.
Publicado: (2023)